NCT02155192View on ClinicalTrials.gov

An Exploratory Genetic Study in Participants With Psoriasis

CompletedOBSERVATIONAL
Enrollment

712

Participants

Timeline

Start Date

March 31, 2014

Primary Completion Date

September 30, 2014

Study Completion Date

September 30, 2014

Conditions
Psoriasis
Interventions
DRUG

No Intervention

Trial Locations (19)

Unknown

Bakersfield

Los Angeles

Ocala

Alpharetta

Arlington Heights

Indianapolis

Louisville

Andover

St Louis

New York

Portland

Webster

Moncton

Hamilton

London

Toronto

Waterloo

Montreal

Québec

All Listed Sponsors
lead

Janssen Research & Development, LLC

INDUSTRY

NCT02155192 - An Exploratory Genetic Study in Participants With Psoriasis | Biotech Hunter | Biotech Hunter